Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516489 · ClinicalTrials.gov registry record · Phase 1
Improving Fecal Occult Blood Test Completion Rates Among Veterans
A Phase 1 study, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 1,549
- Enrollment target
NCT01516489: Completed Phase 1 study, sponsored by Corporal Michael J. Crescenz VA Medical Center.
NCT01516489 is a Phase 1 study that has completed, run by Corporal Michael J. Crescenz VA Medical Center. The registered enrollment target is 1,549 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (2482% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01516489, a Phase 1 study, has completed, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1,549 participants
- Enrollment target
Study Summary
This is a 4-arm cluster randomized controlled trial to evaluate whether patient financial incentives directly integrated into primary care can improve fecal occult blood test (FOBT) completion rates. We will recruit primary care patients at the Philadelphia Veterans Affairs Medical Center (PVAMC) in 2 stages. In stage 1, we hypothesize that, compared to usual care, $5, $10, $20 incentives will each lead to a statistically significant increase in the rate of FOBT completion. We also hypothesize that there will be a direct dose-response relationship between the incentive amount and rates of FOBT completion. In stage 2, we hypothesize that a lottery-based incentive and a raffle-based incentive will both lead to a statistically significant increase in the rate of FOBT completion compared to a fixed payment incentive with an equivalent dollar per patient value.
Interventions
- BEHAVIORAL Stage 1
- BEHAVIORAL Stage 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,549 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
What the finished NCT01516489 record still lists
NCT01516489 is an interventional study that assigns participants to a tested intervention. Its 1,549 participants enrollment target places it among the larger protocols in the corpus, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (2482% higher).
The record links to 0 conditions, and to 2 interventions - of which Stage 1 is the first listed.
NCT01516489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01516489 about?
NCT01516489 is a clinical study titled "Improving Fecal Occult Blood Test Completion Rates Among Veterans". This is a 4-arm cluster randomized controlled trial to evaluate whether patient financial incentives directly integrated into primary care can improve fecal occult blood test (FOBT) completion rates. We will recruit primary care patients at the Philadelphia Veterans Affairs Medical Center (PVAMC) in...
What is the current status of trial NCT01516489?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,549 participants. The study started on 2012-02. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01516489?
The interventions under investigation include: Stage 1 (BEHAVIORAL), Stage 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT01516489?
This trial is sponsored by Corporal Michael J. Crescenz VA Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01516489's enrollment target sits among peer trials
1,549 3rd of 2000 higher than 1,998 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia